Let’s get phygital 2021: transforming from biotech to biopharma
Transforming from biotech to biopharma: creating a new value chain to serve unmet patient needs.
Discover how Galapagos’ supply chain acted as the backbone of their transformation from a biotech to a biopharma company.
By Wouter Keymeulen, VP Quality Galapagos, and Pieter Van den Meutter, Head of Customer Intelligence Bluecrux.
Watch now for free!
Pieter Van den MeutterHead of Customer, Bluecrux
Wouter KeymeulenVP Quality, Galapagos